HER2 Support Group Forums - View Single Post - Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastat

News · 02-23-2016, 04:12 AM

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication expanding the use of IBRANCE (palbociclib) 125mg capsules, Pfizer’s metastatic breast cancer therapy.

More...

02-23-2016, 04:12 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastat Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication expanding the use of IBRANCE (palbociclib) 125mg capsules, Pfizer’s metastatic breast cancer therapy. More...